Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/3065
Full metadata record
DC FieldValueLanguage
dc.contributor.authorArgaman, M-
dc.contributor.authorGidron, Y-
dc.contributor.authorAriad, S-
dc.coverage.spatial11en
dc.date.accessioned2009-02-26T13:06:04Z-
dc.date.available2009-02-26T13:06:04Z-
dc.date.issued2005-
dc.identifier.citationInternational Journal of Behavioral Medicine. 12(3): 16 -170en
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/3065-
dc.description.abstractA model of the relations between psychological factors and cancer progression should include brain and systemic components and their link with critical cellular stages in cancer progression. We present a psychoneuroimmunological (PNI) model that links helplessness-hopelessness (HH) with cancer progression via interleukin-1β (IL-1β). IL-1β was elevated in the brain following exposure to inescapable shock, and HH was minimized by antagonizing cerebral IL-1β. Elevated cerebral IL-1β increased cancer metastasis in animals. Inescapable shock was associated with systemic elevations of IL-1β and peripheral IL-1β was associated with escape from apoptosis, angiogenesis, and metastasis. Involvement of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis are discussed. Future studies need to identify the role of additional factors in this PNI pathway.en
dc.format.extent275591 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoen-
dc.publisherLawrence Erlbaum Associatesen
dc.subjectHopelessness; Cancer; Progression; Psychoneuroimmunology; IL-1βen
dc.titleInterleukin-1 may link helplessness-hopelessness with cancer progression: A proposed modelen
dc.typeResearch Paperen
dc.identifier.doihttp://dx.doi.org/10.1207/s15327558ijbm1203_5-
Appears in Collections:Community Health and Public Health
Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
803101_751310820_784771017.pdf269.13 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.